Market Place
Sourcing Support
Essa drops lead cancer drug after falling short against Xtandi
02 Nov 2024 //
FIERCE BIOTECH
Argenx sees early launch success for Vyvgart in CIDP
02 Nov 2024 //
FIERCE PHARMA
Novo Nordisk`s semaglutide delivers in phase 3 MASH study
02 Nov 2024 //
FIERCE PHARMA
Amgen Whets Investors’ Appetites for MariTide Obesity Data by EoY
01 Nov 2024 //
BIOSPACE
Jade pockets Aerovate in reverse merger
01 Nov 2024 //
FIERCE BIOTECH
Boehringer drops obesity drug from Gubra partnership
01 Nov 2024 //
FIERCE BIOTECH
Teva hit with €463M fine over Copaxone misconduct claims in EU
01 Nov 2024 //
FIERCE PHARMA
FDA expunges all Ozempic, Wegovy doses from shortage list
01 Nov 2024 //
FIERCE PHARMA
FDA advisers vote against Lexicon Pharma`s add-on drug for T1D
01 Nov 2024 //
REUTERS
Abbott, Reckitt cleared of liability in latest preterm formula case
01 Nov 2024 //
REUTERS
Axonis nabs $115M to fill drug-resistant gap in pain, epilepsy
31 Oct 2024 //
BIOPHARMADIVE
Lexeo Encouraging Early Data for Alzheimer’s Gene Therapy
31 Oct 2024 //
GLOBENEWSWIRE
AbbVie`s Skyrizi overtakes Humira as top sales driver
31 Oct 2024 //
FIERCE PHARMA
Patient death prompts Roche to adjust Alzheimer`s trial
31 Oct 2024 //
FIERCE PHARMA
Amgen disappears lung disease program after phase 2 fail
31 Oct 2024 //
FIERCE BIOTECH
UK tucks £520M innovative manufacturing fund into new budget
31 Oct 2024 //
FIERCE PHARMA
Baxter exits China IV fluids market amid US shortage
31 Oct 2024 //
FIERCE PHARMA
FDA says lowest dose of Novo`s weight-loss drug available
31 Oct 2024 //
REUTERS
GSK to acquire Chimagen’s CMG1A46 for autoimmune disease
31 Oct 2024 //
PRESS RELEASE
Novo Nordisk`s Semaglutide Facility Cited by FDA After Inspection
30 Oct 2024 //
ENPTS
Casper Pharma Merger with Suven Pharmaceuticals Cleared
30 Oct 2024 //
ECONOMICTIMES
Exactech Files for Bankruptcy After Recall Litigation
30 Oct 2024 //
REUTERS
McDonald`s Faces Class Action Suit Over E.coli Outbreak
30 Oct 2024 //
REUTERS
PacBio bets on `inflection point` with $500 long-read genome
30 Oct 2024 //
ENDPTS
Novartis` $2.9B MorphoSys bet stumbles as safety delays filing
30 Oct 2024 //
FIERCE BIOTECH
Novartis` Scemblix leaps into newly diagnosed CML
30 Oct 2024 //
FIERCE PHARMA
Shionogi says Phase 3 study showed COVID pill reduces transmission
30 Oct 2024 //
REUTERS
Gradual dosing of Lilly Alzheimer`s drug cuts brain-swelling risk
30 Oct 2024 //
REUTERS
SkinSpirit join Allergan Aesthetics in Empowering New Gen. of Women
30 Oct 2024 //
PRESS RELEASE
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
Piramal Pharma deploying USD 85 mn capex this fiscal
29 Oct 2024 //
ECONOMICTIMES
Lyfius Pharma Penicillin-G plant inaugurated by PM Modi
29 Oct 2024 //
ECONOMICTIMES
Torrent Pharma Promoter to Offload Near 3% Stake Worth ?3,000 Crore
29 Oct 2024 //
CNBCTV
Neurocrine, Idorsia part ways 2 years after double phase 2 fails
29 Oct 2024 //
FIERCE BIOTECH
Awaiting regulator verdict, Innovent posts latest psoriasis win
29 Oct 2024 //
FIERCE BIOTECH
Pfizer lets its RSV pipeline dry up in crowded space
29 Oct 2024 //
FIERCE BIOTECH
Gene therapy reduces harmful protein levels in mouse kidneys
29 Oct 2024 //
FIERCE BIOTECH
TCT: Abbott atherectomy study fails vs. balloon angioplast
29 Oct 2024 //
FIERCE BIOTECH
Boston Scientific`s CMO takes the pulse of pulsed field ablation
29 Oct 2024 //
FIERCE BIOTECH
Medidata boosts CNS trials with Cogstate`s cognitive assessments
29 Oct 2024 //
FIERCE BIOTECH
Pfizer cranks up revenue outlook amid Paxlovid sales bump
29 Oct 2024 //
FIERCE PHARMA
Novartis complies with FDA `flexibility` ask in Pluvicto filing
29 Oct 2024 //
FIERCE PHARMA
BMS partner Zai Lab eyes China filing for KarXT after trial win
29 Oct 2024 //
FIERCE PHARMA
Lilly`s adjusted Kisunla regimen reduces brain swelling in trial
29 Oct 2024 //
FIERCE PHARMA
Novartis Explores Obesity Drugs While Focusing on Growth Areas
29 Oct 2024 //
REUTERS
Straumann`s sales rise, but weak North America drags shares
29 Oct 2024 //
REUTERS
Novartis Raises Yearly Outlook Despite Disappointing Pluvicto
29 Oct 2024 //
REUTERS
Spain`s Mapfre profit surges on benign weather, higher prices
29 Oct 2024 //
REUTERS
Nvidia-Backed AI firm Iambic Unveils Drug Discovery Breakthrough
29 Oct 2024 //
REUTERS
GlaxoSmithKline India Reports Higher Q2 Profit on Strong Demand
29 Oct 2024 //
REUTERS
India`s Cipla beats Q2 profit view on strong US, India demand
29 Oct 2024 //
REUTERS
Incyte raises 2024 sales forecast for top-selling drug Jakafi
29 Oct 2024 //
REUTERS
Saudi wealth fund to cut overseas investments
29 Oct 2024 //
REUTERS
DaVita Misses Q3 Profit Estimates Due to Higher Costs
29 Oct 2024 //
REUTERS
Fewer Australians Support Lockdowns in Future Pandemics
29 Oct 2024 //
REUTERS
Pfizer CEO Defends Turnaround Strategy Amid Activist Pressure
29 Oct 2024 //
REUTERS
Tuberculosis returns as top infectious disease killer, WHO says
29 Oct 2024 //
REUTERS
BioNxt Files Patents for Sublingual Anticancer Drugs in Australia
29 Oct 2024 //
ACCESSWIRE
Amphastar Pharmaceuticals to Release Q3 Earnings on Nov 6, 2024
29 Oct 2024 //
ACCESSWIRE
Quantum Biopharma Announce Sentinel Dosing for Lucid-21-302 Trial
29 Oct 2024 //
ACCESSWIRE
